DJIA 17,813.39 1.20 0.01%
NASDAQ 5,116.14 13.34 0.26%
S&P 500 2,088.87 -0.27 -0.01%
market minute promo

Keryx Biopharmaceuticals (NASDAQ: KERX)

5.49 0.28 (5.37%)

REAL-TIME: Last trade at

Extended Hours: $5.49 $0.00 (0.00%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

KERX $5.49 5.37%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.19
Previous Close $5.21
Daily Range $5.15 - $5.51
52-Week Range $3.04 - $16.50
Market Cap $577.5M
P/E Ratio -4.10
Dividend (Yield) $0.00 (0.0%)
Volume 1,354,575
Average Daily Volume 2,366,473
Current FY EPS -$1.04




Drug Makers

Keryx Biopharmaceuticals (KERX) Description

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer. Website:

News & Commentary Rss Feed

Why Keryx Biopharmaceuticals Rallied 40% in October

A double-dose of good news gets the share price moving in the right direction. But is this a one-time blip or the start of a trend?

How Revance Is Misleading Investors About RT002

Insider Trading Alert - ENOC, QTS And KERX Traded By Insiders

Insider Trading Alert - JASN, HFWA And KERX Traded By Insiders

Why Seth Klarman Keeps Buying Keryx Biopharma

Keryx's Q3: Crunching Numbers

Keryx Q3 Loss Wider-than-Expected, Auryxia in Focus

Perilous Reversal Watch: Keryx Biopharmaceuticals (KERX)

Keryx Biopharmaceuticals' (KERX) CEO Greg Madison on Q3 2015 Results - Earnings Call Transcript

Did Keryx Biopharmaceuticals Inc Finally Turn The Corner?

A good-looking quarterly report sends shares higher, but is this the start of a trend or a one time anomaly?

See More KERX News...

KERX's Top Competitors

KERX $5.49 (5.37%)
Current stock: KERX
BIIB $292.30 (1.09%)
Current stock: BIIB
AMGN $163.95 (0.72%)
Current stock: AMGN
CELG $112.35 (-0.28%)
Current stock: CELG